Trofinetide for the treatment of Rett syndrome: Long-term safety and efficacy results of the 32-month, open-label LILAC-2 study
Titel:
Trofinetide for the treatment of Rett syndrome: Long-term safety and efficacy results of the 32-month, open-label LILAC-2 study
Auteur:
Percy, Alan K. Neul, Jeffrey L. Benke, Timothy A. Berry-Kravis, Elizabeth M. Glaze, Daniel G. Marsh, Eric D. Barrett, Amy M. An, Di Bishop, Kathie M. Youakim, James M.